Lan R

ORCID: 0000-0002-5612-880X · 2 papers in corpus
qualitative 2026
Health expectations : an international journal of public participation in health care and health policy ·doi:10.1111/hex.70534

BACKGROUND: Introduced in 2002, the Essure® implant was promoted as a minimally invasive permanent contraceptive. After widespread use, increasing reports of adverse effects led to its global withdrawal in 2018. This study explores the expe…

nonrandomized-trial 2021
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.15031

AIM: The levonorgestrel-releasing intrauterine (LNG-IUS) system is an effective primary treatment for adenomyosis; however, it has high expulsion rates. We aimed to modify the system-allowing affixion to the myometrium-and evaluate the expu…